04:37 PM EDT, 10/18/2024 (MT Newswires) -- Peter Salzmann, Director, Chief Executive Officer, on October 16, 2024, sold 9,095 shares in Immunovant ( IMVT ) for $261,845. Following the Form 4 filing with the SEC, Salzmann has control over a total of 994,789 shares of the company, with 994,789 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1764013/000176401324000174/xslF345X05/wk-form4_1729283466.xml